Document Detail

Plasminogen activator inhibitor-1 4G allele in the 4G/5G promoter polymorphism increases the occurrence of cerebral ischemia after aneurysmal subarachnoid hemorrhage.
MedLine Citation:
PMID:  15105509     Owner:  NLM     Status:  MEDLINE    
BACKGROUND AND PURPOSE: In several acute life-threatening diseases, the 4G-allele in the 4G/5G-promotor polymorphism in the plasminogen activator inhibitor-1 (PAI-1) gene is associated with higher PAI-1 levels and increased poor outcome, probably by promoting the formation of microthrombi. The aim of the present study was to investigate whether the PAI-1 4G/5G polymorphism is associated with the occurrence of cerebral ischemia, rebleeding, and other events, and clinical outcome after aneurysmal subarachnoid hemorrhage. METHODS: DNA was collected and analyzed in 126 patients with aneurysmal subarachnoid hemorrhage admitted to the Academic Medical Centre Amsterdam and University Medical Centre Utrecht in the Netherlands. All episodes of deterioration were classified according to predefined criteria. Causes of poor outcome and functional outcome were assessed 3 months after the initial bleeding according to the 5-point Glasgow Outcome Scale (GOS). RESULTS: Secondary ischemia occurred more often in patients with the 4G genotype than in patients homozygous for the 5G allele (RR: 3.3; 95% CI: 1.1 to 10.0). No significant differences were found between the groups for rebleeding or other events. Patients with the 4G genotype tended to have a higher risk for poor outcome than patients with the 5G/5G genotype (RR 1.2; 95% CI 0.7 to 2.2). CONCLUSIONS: The 4G allele in the PAI-1 gene increases the risk for cerebral ischemia after aneurysmal subarachnoid hemorrhage (SAH) and probably also the risk for poor outcome. After early aneurysm occlusion, treatment aimed at enhancing fibrinolysis might be effective to prevent and treat cerebral ischemia in patients with aneurysmal SAH.
M D I Vergouwen; C J M Frijns; Y B W E M Roos; G J E Rinkel; F Baas; M Vermeulen
Related Documents :
17685259 - Epidural anaesthesia and mini-laparotomy for the treatment of abdominal aortic aneurysm...
16171579 - Local anesthesia for endovascular abdominal aortic aneurysm repair.
2109049 - Hypermetabolism in the acute stage of hemorrhagic cerebrovascular disease.
7266809 - Overall management of ruptured aneurysm: comparison of early and late operation.
20464529 - Outcome in poor grade subarachnoid hemorrhage patients treated with acute endovascular ...
18358669 - Elective endovascular and open repair of abdominal aortic aneurysms in octogenarians.
23523499 - Wear comparison between conventional and highly cross-linked polyethylene against a zir...
2892989 - Prevention of steroid-induced osteoporosis with (3-amino-1-hydroxypropylidene)-1,1-bisp...
23263679 - Correcting pediatric flatfoot with subtalar arthroereisis and gastrocnemius recession: ...
Publication Detail:
Type:  Journal Article     Date:  2004-04-22
Journal Detail:
Title:  Stroke; a journal of cerebral circulation     Volume:  35     ISSN:  1524-4628     ISO Abbreviation:  Stroke     Publication Date:  2004 Jun 
Date Detail:
Created Date:  2004-05-28     Completed Date:  2004-11-16     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  0235266     Medline TA:  Stroke     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1280-3     Citation Subset:  IM    
Department of Neurology, Academic Medical Center, Amsterdam, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Brain Ischemia / diagnosis,  epidemiology,  genetics*
Intracranial Aneurysm / complications
Middle Aged
Plasminogen Activator Inhibitor 1 / genetics*
Polymorphism, Genetic*
Promoter Regions, Genetic
Subarachnoid Hemorrhage / complications*,  diagnosis,  etiology
Reg. No./Substance:
0/Plasminogen Activator Inhibitor 1

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA):...
Next Document:  Topiramate extends the therapeutic window for hypothermia-mediated neuroprotection after stroke in n...